TY - JOUR
T1 - Dynamical features in fetal and postnatal zinc-copper metabolic cycles predict the emergence of autism spectrum disorder
AU - Emergent Dynamical Systems Group
AU - Curtin, Paul
AU - Austin, Christine
AU - Curtin, Austen
AU - Gennings, Chris
AU - Arora, Manish
AU - Tammimies, Kristiina
AU - Willfors, Charlotte
AU - Berggren, Steve
AU - Siper, Paige
AU - Rai, Dheeraj
AU - Meyering, Kristin
AU - Kolevzon, Alexander
AU - Mollon, Josephine
AU - David, Anthony S.
AU - Lewis, Glyn
AU - Zammit, Stanley
AU - Heilbrun, Lynne
AU - Palmer, Raymond F.
AU - Wright, Robert O.
AU - Bölte, Sven
AU - Reichenberg, Abraham
N1 - Funding Information:
The UK Medical Research Council and Wellcome (grant no. 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. M.A. was supported by the National Institute of Environmental Health Sciences research grants [DP2ES025453, R21ES023604, R01ES026033, P30ES023515, and U2CES026561 (Mount Sinai Children’s Health Exposure Analysis Resource Laboratory Hub–Developmental Core)]. R.O.W. was supported by the National Institute of Environmental Health Sciences research grants (R01ES013744 and P30ES023515). P.C. and C.G. were supported by the National Institute of Environmental Health Sciences research grant (U2C ES026555-01). A.R. was supported by the Beatrice and Samuel A. Seaver Foundation and by the National Institute of Environmental Health Sciences grant P30ES023515. Genotyping was performed by the SNP&SEQ Technology Platform in Uppsala (www.genotyping.se). The facility is part of the National Genomics Infrastructure Sweden and Science for Life Laboratory. The SNP&SEQ Platform is also supported by the Swedish Research Council and the Knut and Alice Wallenberg Foundation. Support was provided by the Innovative Medicines Initiatives Joint Undertaking (grant agreement no. 115300), which comprises financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and in-kind contributions from companies belonging to the European Federation of Pharmaceutical Industries and Associations, the Swedish Research Council (523-2009-7054 and 521-2013-2531), the Swedish Research Council, in partnership with the Swedish Research Council for Health, Working Life and Welfare, Formas and VINNOVA (cross-disciplinary research program concerning children’s and young people’s mental health; 259-2012-24), Stockholm County Council (20100096, 20110602, 20120067, and 20140134), Stiftelsen Frimurare Barnhuset, Sunnerdahls, Handikappfond, Hjärnfonden, and the Swedish Foundation for International Cooperation in Research and Higher Education (STINT; PT2016-6871). A.K. acknowledges support from Vencerx Therapeutics and Ovid Therapeutics, the Simons Foundation Autism Research Initiative-Research Award (345327AK), and National Institute of Neurological Disorders and Stroke (1 U54 NS092090-01).
Publisher Copyright:
Copyright © 2018 The Authors,
PY - 2018/5/30
Y1 - 2018/5/30
N2 - Metals are critical to neurodevelopment, and dysregulation in early life has been documented in autism spectrum disorder (ASD). However, underlying mechanisms and biochemical assays to distinguish ASD cases from controls remain elusive. In a nationwide study of twins in Sweden, we tested whether zinc-copper cycles, which regulate metal metabolism, are disrupted in ASD. Using novel tooth-matrix biomarkers that provide direct measures of fetal elemental uptake, we developed a predictive model to distinguish participants who would be diagnosed with ASD in childhood from those who did not develop the disorder. We replicated our findings in three independent studies in the United States and the UK. We show that three quantifiable characteristics of fetal and postnatal zinc-copper rhythmicity are altered in ASD: the average duration of zinc-copper cycles, regularity with which the cycles recur, and the number of complex features within a cycle. In all independent study sets and in the pooled analysis, zinc-copper rhythmicity was disrupted in ASD cases. In contrast to controls, in ASD cases, the cycle duration was shorter (F = 52.25, P < 0.001), regularity was reduced (F = 47.99, P < 0.001), and complexity diminished (F = 57.30, P < 0.001). With two distinct classification models that used metal rhythmicity data, we achieved 90% accuracy in classifying cases and controls, with sensitivity to ASD diagnosis ranging from 85 to 100% and specificity ranging from 90 to 100%. These findings suggest that altered zinc-copper rhythmicity precedes the emergence of ASD, and quantitative biochemical measures of metal rhythmicity distinguish ASD cases from controls.
AB - Metals are critical to neurodevelopment, and dysregulation in early life has been documented in autism spectrum disorder (ASD). However, underlying mechanisms and biochemical assays to distinguish ASD cases from controls remain elusive. In a nationwide study of twins in Sweden, we tested whether zinc-copper cycles, which regulate metal metabolism, are disrupted in ASD. Using novel tooth-matrix biomarkers that provide direct measures of fetal elemental uptake, we developed a predictive model to distinguish participants who would be diagnosed with ASD in childhood from those who did not develop the disorder. We replicated our findings in three independent studies in the United States and the UK. We show that three quantifiable characteristics of fetal and postnatal zinc-copper rhythmicity are altered in ASD: the average duration of zinc-copper cycles, regularity with which the cycles recur, and the number of complex features within a cycle. In all independent study sets and in the pooled analysis, zinc-copper rhythmicity was disrupted in ASD cases. In contrast to controls, in ASD cases, the cycle duration was shorter (F = 52.25, P < 0.001), regularity was reduced (F = 47.99, P < 0.001), and complexity diminished (F = 57.30, P < 0.001). With two distinct classification models that used metal rhythmicity data, we achieved 90% accuracy in classifying cases and controls, with sensitivity to ASD diagnosis ranging from 85 to 100% and specificity ranging from 90 to 100%. These findings suggest that altered zinc-copper rhythmicity precedes the emergence of ASD, and quantitative biochemical measures of metal rhythmicity distinguish ASD cases from controls.
UR - http://www.scopus.com/inward/record.url?scp=85048012260&partnerID=8YFLogxK
U2 - 10.1126/sciadv.aat1293
DO - 10.1126/sciadv.aat1293
M3 - Article
C2 - 29854952
AN - SCOPUS:85048012260
SN - 2375-2548
VL - 4
JO - Science advances
JF - Science advances
IS - 5
M1 - eaat1293
ER -